Radioimmunoconjugates for targeted alpha therapy

Details for Australian Patent Application No. 2004262943 (hide)

Owner The European Community, represented by the European Commission

Inventors Allen, Barry; Rizvi, Syed; Qu, Chang Fa; Li, Yong

Agent Lord and Company

Pub. Number AU-B-2004262943

PCT Pub. Number WO2005/014052

Priority 2003904201 11.08.03 AU

Filing date 29 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 11 February 2010

International Classifications

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/014052 Priority application(s): WO2005/014052

17 December 2009 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor from On, Chang Fa to Qu, Chang Fa

11 February 2010 Application Accepted

  Published as AU-B-2004262943

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262959-Device for aiding the percutaneous positioning of a guiding tube for a nephroscope in kidney surgery

2004262940-Securing device